Ortho Clinical Diagnostics Holdings plc·4

Oct 19, 4:15 PM ET

Schlesinger Michael A. 4

4 · Ortho Clinical Diagnostics Holdings plc · Filed Oct 19, 2021

Insider Transaction Report

Form 4
Period: 2021-10-15
Schlesinger Michael A.
EVP, GC and Secretary
Transactions
  • Exercise/Conversion

    Ordinary Shares, $0.00001 par value

    2021-10-15$6.28/sh+75,464$473,914163,101 total
  • Sale

    Ordinary Shares, $0.00001 par value

    2021-10-15$19.73/sh75,464$1,489,01087,637 total
  • Exercise/Conversion

    Stock Option

    2021-10-1575,464218,043 total
    Exercise: $6.28Exp: 2024-10-22Ordinary Shares, $0.00001 par value (75,464 underlying)
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
  • [F3]Represents the weighted average sales price for the price increments ranging from $19.5900 to $19.9200.
  • [F4]The stock option is fully vested and exercisable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION